Prevalence of metabolic syndrome and its components in a Brazilian sample of Pemphigus patients

Anais Brasileiros de Dermatologia

Volumn 89, Issue 5, 2014, Pages 752-756

  Ambiel, Marcela Vendruscolo ^a   Roselino, Ana Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Abdominal; Diabetes mellitus; Dyslipidemias; Glucocorticoids; Metabolic syndrome X; Obesity; Pemphigus; Triglycerides

Indexed keywords

CORTICOSTEROID; STEROID;

ADULT; BRAZIL; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PEMPHIGUS; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; BRAZIL; DIABETES MELLITUS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PEMPHIGUS; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; STEROIDS; YOUNG ADULT;

EID: 84906904060     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/abd1806-4841.20142930     Document Type: Article

References (23)

1. Grando SA. Pemphigus autoimmunity: hypotheses and realities. Autoimmunity. 2012;45:7-35.
2. Flores G, Qian Y, Díaz LA. The enigmatic autoimmune response in endemic pemphigus foliaceus. Actas Dermosifiliogr. 2009;100:40-48.
3. Abréu-Vélez AM, Reason IJ, Howard Met S, Roselino AM. Endemic pemphigus foliaceus over a century: Part I. N Am J Med Sci. 2010;2:51-59.
4. Abréu-Vélez AM, Roselino AM, Howard MS, Reason IJ. Endemic pemphigus over a century: Part II. N Am J Med Sci. 2010;2:114-125.
5. Gonçalves GA, Brito MM, Salathiel AM, Ferraz TS, Alves D, Roselino AM. Incidence of pemphigus vulgaris exceeds that of pemphigus foliaceus in a region where pemphigus foliaceus is endemic: analysis of a 21-year historical series. An Bras Dermatol. 2011;86:1109-1112.
6. Chriguer RS, Roselino AM, De Castro M. Glucocorticoid Sensitivity and Proinflammatory Cytokines Pattern in Pemphigus. J Clin Immunol. 2012;32:786-793.
7. Rosatelli TB, Roselino AM, Dellalibera-Joviliano R, Reis ML, Donadi EA. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem). Br J Dermatol. 2005;152:650-657.
8. Chiossi MP, Costa RS, Roselino AM. Dermal dendritic cell number correlates with serum autoantibody titers in Brazilian pemphigus foliaceus patients. Braz J Med Biol Res. 2004;37:337-341.
9. Zuccolotto I, Roselino AM, Ramalho LN, Zucoloto S. Apoptosis and p63 expression in the pathogenesis of bullous lesions of endemic pemphigus foliaceus. Arch Dermatol Res. 2003;295:284-286.
10. Zeoti DM, Figueiredo JF, Chiossi M P, Roselino AM. Serum cytokines in patients with Brazilian pemphigus foliaceus (fogo selvagem). Braz J Med Biol Res. 2000;33:1065-1068.
11. Kasperkiewicz M, Schmidt E, Zillikens D. Current therapy of the pemphigus group. Clin Dermatol. 2012;30:84-94.
12. Kaur S, Kanwar AJ. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol. 1990;29:371-374.
13. Salopek TG, Logsetty S, Tredget EE. Anti-CD20 chimeric monoclonal antibody (rituxi-mab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder. J Am Acad Dermatol. 2002;47:785-788.
14. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
15. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C et al. American Heart Association; Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation. 2004;109:433-438.
16. Lindsay RS, Howard BV. Cardiovascular risk associated with the metabolic syndrome. Curr Diab Rep. 2004;4:63-68.
17. Kelliny C, William J, Riesen W, Paccaud F, Bovet P. Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol. 2008;7:27.
18. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
19. Wajchenberg BL, Nery M, Cunha MR, Silva ME. Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis. Arq Bras Endocrinol Metabol. 2009;53:145-150.
20. Laroli LB, Barbosa GC, Mill JG, Molina MCB. Prevalence of metabolic syndrome in population-based study, Vitória, ES-Brazil. Arq Bras Endocrinol Metabol. 2007;51:1143-1152.
21. Da Cunha S F, dos Santos VM, Monteiro JP, Ferreira TP, dos Santos JA, dos Santos TA, et al. Serum lipids of pemphigus foliaceus patients on long-term glucocorticoid therapy. Rev Soc Bras Med Trop. 2003;36:1-4.
22. Wohl Y, Dreiher J, Cohen AD. Pemphigus and dyslipidemia: a case-control study. Br J Dermatol. 2009;161:1418-1420.
23. Bvsms.saude.gov.br [Internet]. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Secretaria de Gestão Estratégica e Participativa. Vigitel Brasil 2008: vigilância de fatores de risco e de proteção para doenças crônicas por inquérito telefônico. Brasília: Ministério da Saúde; 2009. [acesso em 22 Ago 2009]. Disponível em: http://bvsms.saude.gov.br/bvs/publicacoes/vigitel_2008.pdf